JnJ seeks USFDA approval for Icotrokinra to treat plaque psoriasis in adults, adolescents

By Dr. Kamal Kant Kohli Ruchika Sharma

Icotrokinra was jointly discovered and is being developed pursuant to the license and collaboration agreement between Protagonist and Johnson & Johnson.

Read More…